MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

Exclusion Criteria

• •Known allergy to any component of the investigational drug.
• •Active ocular infection.
• •Presence of other significant ocular disease or trauma diagnosed prior to enrollment, including but not limited to glaucoma, uveitis, retinopathy, chemical injury, or thermal burns.
• •History of any ocular surgery within the preceding 6 months, including cataract surgery.
• •Participation in another interventional clinical study.
• •Use of any ophthalmic medication that may interfere with the study outcomes, such as other stem-cell-derived products.
• •Having serious underlying diseases of the heart, brain vessels, liver, kidneys, and hematopoietic system.
• •Pregnant or lactating women; women of childbearing potential must employ an effective contraceptive method (e.g., intrauterine device, oral contraceptive, or condom) during the study and for at least 3 months after the final dose of study drug.
• •Subjects deemed unsuitable for participation in this trial by the investigator.